REFORGENE
Live / Registered — Registered (as of 28 Feb 2023)
What this means for you
Registered since 28 Feb 2023. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97311915
- Registration number
- 6991565
- Mark type
- Stylized text
- Filed
- 14 Mar 2022
- Published for opposition
- 13 Dec 2022
- Registered
- 28 Feb 2023
- Attorney of record
- Nazly Aileen Bayramoglu
Goods and services
- Class 005 — Pharmaceuticals: Reagents for medical use; Biological preparations for the treatment of eye diseases, hemoglobinopathy, cancer, nervous system diseases, pulmonary fibrosis, cardiomyopathy, dyslipidemia; Pharmaceutical preparations for the treatment of eye diseases, hemoglobinopathy, cancer, nervous system diseases, pulmonary fibrosis, cardiomyopathy, dyslipidemia; stem cells for medical purposes; pharmaceutical and biological preparations based on gene, genome and cellular editing, modulation, modification, engineering, regulation, repair and therapy for use in human therapeutics
Owner
- GUANGZHOU REFORGENE MEDICINE CO., LTD., Guangzhou, Guangdong, CN
- GUANGZHOU REFORGENE MEDICINE CO., LTD., Guangzhou, Guangdong, CN
- GUANGZHOU REFORGENE MEDICINE CO., LTD., Guangzhou, Guangdong, CN
Prosecution history
- 28 Feb 2023 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 28 Feb 2023 — REGISTERED-PRINCIPAL REGISTER
- 13 Dec 2022 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 13 Dec 2022 — PUBLISHED FOR OPPOSITION
- 23 Nov 2022 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 08 Nov 2022 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 05 Nov 2022 — ASSIGNED TO EXAMINER
- 18 Mar 2022 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 17 Mar 2022 — NEW APPLICATION ENTERED